Dr. Amatruda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
15 West 81 Steeet
New York, NY 10024Phone+1 917-930-4796Fax+1 212-362-6726- Is this information wrong?
Education & Training
Johns Hopkins UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1973 - 1975- Johns Hopkins UniversityResidency, Internal Medicine, 1970 - 1975
Medical College of WisconsinClass of 1970
Certifications & Licensure
NY State Medical License 1977 - 2024
CT State Medical License 1992 - 2009
MD State Medical License 1974 - 1978- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1982
Publications & Presentations
PubMed
- 38 citationsEfficacy and safety of sitagliptin added to ongoing metformin and rosiglitazone combination therapy in a randomized placebo-controlled 54-week trial in patients with t...Adrian S. Dobs, Barry J. Goldstein, Pablo Aschner, Edward S. Horton, Guillermo E. Umpierrez, Lorraine Duran, Julie Hill, Yu Chen, Gregory T. Golm, Ronald B. Langdon, D...> ;Journal of Diabetes. 2013 Mar 1
- 18 citationsSitagliptin added to treatment with ongoing pioglitazone for up to 52 weeks improves glycemic control in Japanese patients with type 2 diabetesAtsunori Kashiwagi, Takashi Kadowaki, Naoko Tajima, Kenji Nonaka, Tadaaki Taniguchi, Mikio Nishii, Juan Camilo Arjona Ferreira, John M. Amatruda> ;Journal of Diabetes Investigation. 2011 Oct 1
- 103 citationsEfficacy and tolerability of sitagliptin monotherapy in elderly patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trialNir Barzilai, Hua Guo, Erin Mahoney, Suzanne Caporossi, Gregory T. Golm, Ronald B. Langdon, D. E. Williams-Herman, Keith D. Kaufman, John M. Amatruda, Barry J. Goldste...> ;Current Medical Research and Opinion. 2011 Apr 14
- Join now to see all
Press Mentions
Why Are We Still so Fat?November 19th, 2018
Boston Therapeutics Creates New Scientific Advisory BoardMarch 27th, 2018
Grant Support
- Metabolic Rate And Protein Turnover In ObesityNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1996
- Metabolic Rate And Protein Turnover In ObesityNational Center For Research Resources1992–1993
- Insulin Action In The LiverNational Institute Of Diabetes And Digestive And Kidney Diseases1988–1992
- Metabolic Rate And Protein Turnover In ObesityNational Institute Of Diabetes And Digestive And Kidney Diseases1989–1991
- Metabotic Rate And Protein Turnover In ObesityNational Center For Research Resources1990
- Insulin Binding Action And DegradationNational Institute Of Diabetes And Digestive And Kidney Diseases1986
- Protein Sparing FAST In The Treatment Of Simple ObesityNational Center For Research Resources1985
- Protein Fasts In Treatment Of Obesity And Type II Diabetes MellitusNational Center For Research Resources1985
- Insulin Binding Action And DegradationNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985
Hospital Affiliations
Montefiore Medical CenterBronx, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
